The epidemiology of human papillomaviruses

Current Problems in Dermatology (Switzerland)

Volumn 45, Issue , 2014, Pages 75-91

  Nyitray, Alan G ^a   Iannacone, Michelle R ^b  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANUS CANCER; ARTICLE; BASAL CELL CARCINOMA; CANCER RISK; CLINICAL TRIAL (TOPIC); CONDYLOMA ACUMINATUM; FEMALE; GENITAL TRACT INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS (TOPIC); MOUTH CANCER; MOUTH INFECTION; NEOPLASM; OROPHARYNX CANCER; PAPILLOMAVIRUS INFECTION; PENIS CANCER; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEROLOGY; SEXUAL BEHAVIOR; SKIN CANCER; SKIN DISEASE; UTERINE CERVIX CANCER; VAGINA CANCER; VULVA CANCER; WART VIRUS; PAPILLOMAVIRUS INFECTIONS; SEXUALLY TRANSMITTED DISEASES, VIRAL; SKIN DISEASES, VIRAL; UROGENITAL NEOPLASMS; VIROLOGY;

FEMALE; HUMANS; MALE; PAPILLOMAVIRUS INFECTIONS; RISK FACTORS; SEXUALLY TRANSMITTED DISEASES, VIRAL; SKIN DISEASES, VIRAL; UROGENITAL NEOPLASMS;

EID: 84905462033     PISSN: 14215721     EISSN: 16622944     Source Type: Book Series    
DOI: 10.1159/000358370     Document Type: Article

References (163)

1. Bernard H-U, Burk RD, Chen Z, van Doorslaer K, Hausen Hz, de Villiers E-M: Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 2010; 401: 70-79
2. Zur Hausen H: Roots and perspectives of contemporary papillomavirus research. J Cancer Res Clin Oncol 1996; 122: 3-13
3. De Villiers E-M: HPV infection of skin. 23rd International Papillomavirus Conference and Clinical Workshop, Prague, September 1-7, 2006
4. Partridge JM, Hughes JP, Feng Q, Winer RL, Weaver BA, Xi LF, Stern ME, Lee SK, O'Reilly SF, Hawes SE, Kiviat NB, Koutsky LA: Genital human papillomavirus infection in men: incidence and risk factors in a cohort of university students. J Infect Dis 2007; 196: 1128-1136
5. Hernandez BY, Wilkens LR, Zhu X, Thompson P, McDuffie K, Shvetsov YB, Kamemoto LE, Killeen J, Ning L, Goodman MT: Transmission of human papillomavirus in heterosexual couples. Emerg Infect Dis 2008; 14: 888-894
6. Burchell AN, Winer RL, de Sanjose S, Franco EL: Chapter 6: epidemiology and transmission dynamics of genital HPV infection. Vaccine 2006; 24(suppl 3): S52-S61
7. Nielson CM, Harris RB, Dunne EF, Abrahamsen M, Papenfuss MR, Flores R, Markowitz LE, Giuliano AR: Risk factors for anogenital human papillomavirus infection in men. J Infect Dis 2007; 196: 1137-1145
8. Bleeker MC, Hogewoning CJ, Berkhof J, Voorhorst FJ, Hesselink AT, van Diemen PM, van den Brule AJ, Snijders PJ, Meijer CJ: Concordance of specific human papillomavirus types in sex partners is more prevalent than would be expected by chance and is associated with increased viral loads. Clin Infect Dis 2005; 41: 612-620
9. Sonnex C, Strauss S, Gray JJ: Detection of human papillomavirus DNA on the fingers of patients with genital warts. Sex Transm Infect 1999; 75: 317-319
10. Koutsky L: Epidemiology of genital human papillomavirus infection. Am J Med 1997; 102: 3-8
11. Bouwes Bavinck JN, Neale RE, Abeni D, Euvrard S, Green AC, Harwood CA, de Koning MN, Naldi L, Nindl I, Pawlita M, Pfister H, Proby CM, Quint WG, ter Schegget J, Waterboer T, Weissenborn S, Feltkamp MC, group E-H-U-C: Multicenter study of the association between betapapillomavirus infection and cutaneous squamous cell carcinoma. Cancer Res 2010; 70: 9777-9786
12. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V: A review of human carcinogens-part B: biological agents. Lancet Oncol 2009; 10: 321-322
13. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV: Prevalence of human papillomavirus in cervical cancer: A worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group. J Natl Cancer Inst 1995; 87: 796-802
14. Daling JR, Madeleine MM, Johnson LG, Schwartz SM, Shera KA, Wurscher MA, Carter JJ, Porter PL, Galloway DA, McDougall JK: Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer 2004; 101: 270-280
15. De Vuyst H, Clifford GM, Nascimento MC, Madeleine MM, Franceschi S: Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: A meta-analysis. Int J Cancer 2009; 124: 1626-1636
16. Parkin DM, Bray F: The burden of HPV-related cancers. Vaccine 2006; 24: 11-25
17. Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, Markowitz LE: Prevalence of HPV infection among females in the United States. JAMA 2007; 297: 813-819
18. De Sanjose S, Diaz M, Castellsague X, Clifford G, Bruni L, Munoz N, Bosch FX: Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: A meta-analysis. Lancet Infect Dis 2007; 7: 453-459
19. Marrazzo JM, Stine K, Koutsky LA: Genital human papillomavirus infection in women who have sex with women: A review. Am J Obstet Gynecol 2000; 183: 770-774
20. Schlecht NF, Burk RD, Nucci-Sack A, Shankar V, Peake K, Lorde-Rollins E, Porter R, Linares LO, Rojas M, Strickler HD, Diaz A: Cervical, anal and oral HPV in an adolescent inner-city health clinic providing free vaccinations. PLoS One 2012; 7:e37419
21. IARC: Human papillomaviruses/IARC working group on the evaluation of carcinogenic risks to humans. Lyon, International Agency for Research on Cancer 2007
22. Insinga RP, Perez G, Wheeler CM, Koutsky LA, Garland SM, Leodolter S, Joura EA, Ferris DG, Steben M, Brown DR, Elbasha EH, Paavonen J, Haupt RM: Incidence, duration, and reappearance of type-specific cervical human papillomavirus infections in young women. Cancer Epidemiol Biomarkers Prev 2010; 19: 1585-1594
23. Moscicki A-B, Schiffman M, Burchell A, Albero G, Giuliano AR, Goodman MT, Kjaer SK, Palefsky J: Updating the natural history of human papillomavirus and anogenital cancers. Vaccine 2012; 30(suppl 5): F24-F33
24. Plummer M, Schiffman M, Castle PE, Maucort-Boulch D, Wheeler CM: A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion. J Infect Dis 2007; 195: 1582-1589
25. Bosch FX, de Sanjose S: The epidemiology of human papillomavirus infection and cervical cancer. Dis Markers 2007; 23: 213-227
26. Moscicki AB, Schiffman M, Kjaer S, Villa LL: Chapter 5: updating the natural history of HPV and anogenital cancer. Vaccine 2006; 24(suppl 3):S42-S51
27. Rodriguez AC, Schiffman M, Herrero R, Wacholder S, Hildesheim A, Castle PE, Solomon D, Burk R: Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections. J Natl Cancer Inst 2008; 100: 513-517
28. Sellors JW, Karwalajtys TL, Kaczorowski J, Mahony JB, Lytwyn A, Chong S, Sparrow J, Lorincz A, Grp S: Incidence, clearance and predictors of human papillomavirus infection in women. Can Med Assoc J 2003; 168: 421-425
29. Dillner J, Andersson-Ellstrom A, Hagmar B, Schiller J: High risk genital papillomavirus infections are not spread vertically. Rev Med Virol 1999; 9: 23-29
30. Winer RL, Lee SK, Hughes JP, Adam DE, Kiviat NB, Koutsky LA: Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol 2003; 157: 218-226
31. Giuliano AR, Papenfuss M, Abrahamsen M, Inserra P: Differences in factors associated with oncogenic and nononcogenic human papillomavirus infection at the United States-Mexico border. Cancer Epidemiol Biomarkers Prev 2002; 11: 930-934
32. Castellsague X, Bosch FX, Munoz N: The male role in cervical cancer. Salud Publica Mex 2003; 45(suppl 3): S345-S353
33. Burchell AN, Tellier PP, Hanley J, Coutlee F, Franco EL: Influence of partner's infection status on prevalent human papillomavirus among persons with a new sex partner. Sex Transm Dis 2010; 37: 34-40
34. Giuliano AR, Sedjo RL, Roe DJ, Harri R, Baldwi S, Papenfuss MR, Abrahamsen M, Inserra P: Clearance of oncogenic human papillomavirus (HPV) infection: effect of smoking (United States). Cancer Cause Control 2002; 13: 839-846
35. Matsumoto K, Oki A, Furuta R, Maeda H, Yasugi T, Takatsuka N, Hirai Y, Mitsuhashi A, Fujii T, Iwasaka T, Yaegashi N, Watanabe Y, Nagai Y, Kitagawa T, Yoshikawa H, Japan HPV and Cervical Cancer Study Group: Tobacco smoking and regression of lowgrade cervical abnormalities. Cancer Sci 2010; 101: 2065-2073
36. Munoz N, Hernandez-Suarez G, Mendez F, Molano M, Posso H, Moreno V, Murillo R, Ronderos M, Meijer C, Munoz A, Grp IHS: Persistence of HPV infection and risk of high-grade cervical intraepithelial neoplasia in a cohort of Colombian women. Br J Cancer 2009; 100: 1184-1190
37. Dunne EF, Nielson CM, Stone KM, Markowitz LE, Giuliano AR: Prevalence of HPV infection among men: A systematic review of the literature. J Infect Dis 2006; 194: 1044-1057
38. Giuliano AR, Lazcano-Ponce E, Villa LL, Flores R, Salmeron J, Lee JH, Papenfuss MR, Abrahamsen M, Jolles E, Nielson CM, Baggio ML, Silva R, Quiterio M: The Human Papillomavirus Infection in Men Study: human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States. Cancer Epidemiol Biomarkers Prev 2008; 17: 2036-2043
39. Nyitray AGP, Carvalho da Silva RJMDP, Baggio MLBS, Lu BP, Smith D, Abrahamsen MMPH, Papenfuss MMS, Quiterio MMS, Villa LLP, Giuliano ARP: The prevalence of genital HPV and factors associated with oncogenic HPV among men having sex with men and men having sex with women and men: the HIM Study. Sex Transm Dis 2011; 38: 932-940
40. Giuliano AR, Lu B, Nielson CM, Flores R, Papenfuss MR, Lee JH, Abrahamsen M, Harris RB: Age-specific prevalence, incidence, and duration of human papillomavirus infections in a cohort of 290 US men. J Infect Dis 2008; 198: 827-835
41. Giuliano AR, Harris R, Sedjo RL, Baldwin S, Roe D, Papenfuss MR, Abrahamsen M, Inserra P, Olvera S, Hatch K: Incidence, prevalence, and clearance of type-specific human papillomavirus infections: the Young Women's Health Study. J Infect Dis 2002; 186: 462-469
42. Giuliano AR, Lee JH, Fulp W, Villa LL, Lazcano E, Papenfuss MR, Abrahamsen M, Salmeron J, Anic GM, Rollison DE, Smith D: Incidence and clearance of genital human papillomavirus infection in men (HIM): A cohort study. Lancet 2011; 377: 932-940
43. Nyitray AG, Carvalho da Silva RJ, Baggio ML, Lu B, Smith D, Abrahamsen M, Papenfuss M, Villa LL, Lazcano-Ponce E, Giuliano AR: Age-specific prevalence of and risk factors for anal human papillomavirus (HPV) among men who have sex with women and men who have sex with men: the HPV in Men (HIM) Study. J Infect Dis 2011; 203: 49-57
44. Nyitray A, Nielson CM, Harris RB, Flores R, Abrahamsen M, Dunne EF, Giuliano AR: Prevalence of and risk factors for anal human papillomavirus infection in heterosexual men. J Infect Dis 2008; 197: 1676-1684
45. D'Hauwers KW, Cornelissen T, Depuydt CE, Bogers J, Donders AR, Leuridan E, Van Damme P, Tjalma WA: Anal human papillomavirus DNA in women at a colposcopy clinic. Eur J Obstet Gynecol Reprod Biol 2012; 164: 69-73
46. Hernandez BY, McDuffie K, Zhu X, Wilkens LR, Killeen J, Kessel B, Wakabayashi MT, Bertram CC, Easa D, Ning L, Boyd J, Sunoo C, Kamemoto L, Goodman MT: Anal human papillomavirus infection in women and its relationship with cervical infection. Cancer Epidemiol Biomarkers Prev 2005; 14: 2550-2556
47. Palefsky JM, Holly EA, Ralston ML, Da Costa M, Greenblatt RM: Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women. J Infect Dis 2001; 183: 383-391
48. Castro FA, Quint W, Gonzalez P, Katki HA, Herrero R, Van Doorn LJ, Schiffman M, Struijk L, Rodriguez AC, Delvecchio C, Lowy DR, Porras C, Jimenez S, Schiller J, Solomon D, Wacholder S, Hildesheim A, Kreimer AR: Prevalence of and risk factors for anal human papillomavirus infection among young healthy women in Costa Rica. J Infect Dis 2012; 206: 1103-1110
49. Chin-Hong PV, Vittinghoff E, Cranston RD, Buchbinder S, Cohen D, Colfax G, Da Costa M, Darragh T, Hess E, Judson F, Koblin B, Madison M, Palefsky JM: Age-specific prevalence of anal human papillomavirus infection in HIV-negative sexually active men who have sex with men: the EXPLORE study. J Infect Dis 2004; 190: 2070-2076
50. Donà MG, Palamara G, Di Carlo A, Latini A, Vocaturo A, Benevolo M, Pimpinelli F, Giglio A, Moretto D, Impara G, Giuliani M: Prevalence, genotype diversity and determinants of anal HPV infection in HIV-uninfected men having sex with men. J Clin Virol 2012; 54: 185-189
51. Machalek DA, Poynten M, Jin F, Fairley CK, Farnsworth A, Garland SM, Hillman RJ, Petoumenos K, Roberts J, Tabrizi SN, Templeton DJ, Grulich AE: Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: A systematic review and meta-analysis. Lancet Oncol 2012; 13: 487-500
52. Goodman MT, Shvetsov YB, McDuffie K, Wilkens LR, Zhu X, Ning L, Killeen J, Kamemoto L, Hernandez BY: Acquisition of anal human papillomavirus (HPV) infection in women: the Hawaii HPV Cohort Study. J Infect Dis 2008; 197: 957-966
53. Shvetsov YB, Hernandez BY, McDuffie K, Wilkens LR, Zhu XM, Ning L, Killeen J, Kamemoto L, Goodman MT: Duration and clearance of anal human papillomavirus (HPV) infection among women: the Hawaii HPV Cohort Study. Clin Infect Dis 2009; 48: 536-546
54. Critchlow CW, Hawes SE, Kuypers JM, Goldbaum GM, Holmes KK, Surawicz CM, Kiviat NB: Effect of HIV infection on the natural history of anal human papillomavirus infection. AIDS 1998; 12: 1177-1184
55. Chin-Hong PV, Husnik M, Benet DJ, Buchbinder S, Colfax G, Cranston RD, Da Costa M, Judson F, Koblin B, Mayer KH, Herrera R, Palefsky J: High incidence and persistence of anal human papillomavirus infection among HIV-negative sexually active men who have sex with men: the EXPLORE Study. 24th International Papillomavirus Conference and Clinical Workshop, Beijing, November 3-9, 2007
56. Palefsky JM, Holly EA, Ralston ML, Jay N, Berry JM, Darragh TM: High incidence of anal high-grade squamous intra-epithelial lesions among HIV-positive and HIV-negative homosexual and bisexual men. AIDS 1998; 12: 495-503
57. Palefsky JM, Holly EA, Hogeboom CJ, Ralston ML, DaCosta MM, Botts R, Berry JM, Jay N, Darragh TM: Virologic, immunologic, and clinical parameters in the incidence and progression of anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual men. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 17: 314-319
58. Critchlow CW, Surawicz CM, Holmes KK, Kuypers J, Daling JR, Hawes SE, Goldbaum GM, Sayer J, Hurt C, Dunphy C, et al: Prospective study of high grade anal squamous intraepithelial neoplasia in a cohort of homosexual men: influence of HIV infection, immunosuppression and human papillomavirus infection. AIDS 1995; 9: 1255-1262
59. Daling JR, Weiss NS, Hislop TG, Maden C, Coates RJ, Sherman KJ, Ashley RL, Beagrie M, Ryan JA, Corey L: Sexual practices, sexually transmitted diseases, and the incidence of anal cancer. N Engl J Med 1987; 317: 973-977
60. Holly EA, Whittemore AS, Aston DA, Ahn DK, Nickoloff BJ, Kristiansen JJ: Anal cancer incidence: genital warts, anal fissure or fistula, hemorrhoids, and smoking. J Natl Cancer Inst 1989; 81: 1726-1731
61. Gillison ML, Broutian T, Pickard RK, Tong ZY, Xiao W, Kahle L, Graubard BI, Chaturvedi AK: Prevalence of oral HPV infection in the United States, 2009-2010. JAMA 2012; 307: 693-703
62. Kreimer AR, Bhatia RK, Messeguer AL, Gonzalez P, Herrero R, Giuliano AR: Oral human papillomavirus in healthy individuals: A systematic review of the literature. Sex Transm Dis 2010; 37: 386-391
63. Kreimer AR, Clifford GM, Boyle P, Franceschi S: Human papillomavirus types in head and neck squamous cell carcinomas worldwide: A systematic review. Cancer Epidemiol Biomarkers Prev 2005; 14: 467-475
64. D'Souza G, Agrawal Y, Halpern J, Bodison S, Gillison ML: Oral sexual behaviors associated with prevalent oral human papillomavirus infection. J Infect Dis 2009; 199: 1263-1269
65. Fakhry C, D'Souza G, Sugar E, Weber K, Goshu E, Minkoff H, Wright R, Seaberg E, Gillison M: Relationship between prevalent oral and cervical human papillomavirus infections in human immunodeficiency virus-positive and-negative women. J Clin Microbiol 2006; 44: 4479-4485
66. Rintala M, Grenman S, Puranen M, Syrjanen S: Natural history of oral papillomavirus infections in spouses: A prospective Finnish HPV family study. J Clin Virol 2006; 35: 89-94
67. D'Souza G, Fakhry C, Sugar EA, Seaberg EC, Weber K, Minkoff HL, Anastos K, Palefsky JM, Gillison ML: Sixmonth natural history of oral versus cervical human papillomavirus infection. Int J Cancer 2007; 121: 143-150
68. Fakhry C, Sugar E, D'Souza G, Gillison M: Twoweek versus six-month sampling interval in a shortterm natural history study of oral HPV infection in an HIV-positive cohort. PLoS One 2010; 5:e11918
69. Antonsson A: Review: antibodies to cutaneous human papillomaviruses. J Med Virol 2012;84:814-822
70. Iannacone MR, Gheit T, Waterboer T, et al: Casecontrol study of cutaneous human papillomavirus infection in Basal cell carcinoma of the skin. J Invest Dermatol 2013;133:1512-1520
71. Iannacone MR, Gheit T, Waterboer T, et al: Casecontrol study of cutaneous human papillomaviruses in squamous cell carcinoma of the skin. Cancer Epidemiol Biomarkers Prev 2012;21:1303-1313
72. Asgari MM, Kiviat NB, Critchlow CW, Stern JE, Argenyi ZB, Raugi GJ, Berg D, Odland PB, Hawes SE, de Villiers EM: Detection of human papillomavirus DNA in cutaneous squamous cell carcinoma among immunocompetent individuals. J Invest Dermatol 2008; 128: 1409-1417
73. Boxman IL, Berkhout RJ, Mulder LH, Wolkers MC, Bouwes Bavinck JN, Vermeer BJ, ter Schegget J: Detection of human papillomavirus DNA in plucked hairs from renal transplant recipients and healthy volunteers. J Invest Dermatol 1997; 108: 712-715
74. Forslund O, Antonsson A, Nordin P, Stenquist B, Hansson BG: A broad range of human papillomavirus types detected with a general PCR method suitable for analysis of cutaneous tumours and normal skin. J Gen Virol 1999; 80: 2437-2443
75. Forslund O, Ly H, Reid C, Higgins G: A broad spectrum of human papillomavirus types is present in the skin of Australian patients with non-melanoma skin cancers and solar keratosis. Br J Dermatol 2003; 149: 64-73
76. Harwood CA, Surentheran T, Sasieni P, Proby CM, Bordea C, Leigh IM, Wojnarowska F, Breuer J, Mc-Gregor JM: Increased risk of skin cancer associated with the presence of epidermodysplasia verruciformis human papillomavirus types in normal skin. Br J Dermatol 2004; 150: 949-957
77. Hazard K, Karlsson A, Andersson K, Ekberg H, Dillner J, Forslund O: Cutaneous human papillomaviruses persist on healthy skin. J Invest Dermatol 2007; 127: 116-119
78. Antonsson A, Forslund O, Ekberg H, Sterner G, Hansson BG: The ubiquity and impressive genomic diversity of human skin papillomaviruses suggest a commensalic nature of these viruses. J Virol 2000; 74: 11636-11641
79. Boxman IL, Russell A, Mulder LH, Bavinck JN, ter Schegget J, Green A: Case-control study in a subtropical Australian population to assess the relation between non-melanoma skin cancer and epidermodysplasia verruciformis human papillomavirus DNA in plucked eyebrow hairs. The Nambour Skin Cancer Prevention Study Group. Int J Cancer 2000; 86: 118-121
80. Struijk L, Hall L, van der Meijden E, Wanningen P, Bavinck JN, Neale R, Green AC, ter Schegget J, Feltkamp MC: Markers of cutaneous human papillomavirus infection in individuals with tumor-free skin, actinic keratoses, and squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2006; 15: 529-535
81. Struijk L, Bouwes Bavinck JN, Wanningen P, van der Meijden E, Westendorp RG, ter Schegget J, Feltkamp MC: Presence of human papillomavirus DNA in plucked eyebrow hairs is associated with a history of cutaneous squamous cell carcinoma. J Invest Dermatol 2003; 121: 1531-1535
82. Termorshuizen F, Feltkamp MC, Struijk L, de Gruijl FR, Bavinck JN, van Loveren H: Sunlight exposure and (sero)prevalence of epidermodysplasia verruciformis-associated human papillomavirus. J Invest Dermatol 2004; 122: 1456-1462
83. Iannacone MR, Gheit T, Pfister H, et al: Case-control study of genus-beta human papillomaviruses in plucked eyebrow hairs and cutaneous squamous cell carcinoma. Int J Cancer 2013
84. Berkhout RJ, Bouwes Bavinck JN, ter Schegget J: Persistence of human papillomavirus DNA in benign and (pre)malignant skin lesions from renal transplant recipients. J Clin Microbiol 2000; 38: 2087-2096
85. De Villiers EM, Lavergne D, McLaren K, Benton EC: Prevailing papillomavirus types in non-melanoma carcinomas of the skin in renal allograft recipients. Int J Cancer 1997; 73: 356-361
86. Harwood CA, Surentheran T, McGregor JM, Spink PJ, Leigh IM, Breuer J, Proby CM: Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals. J Med Virol 2000; 61: 289-297
87. Mackintosh LJ, de Koning MN, Quint WG, ter Schegget J, Morgan IM, Herd RM, Campo MS: Presence of beta human papillomaviruses in nonmelanoma skin cancer from organ transplant recipients and immunocompetent patients in the West of Scotland. Br J Dermatol 2009; 161: 56-62
88. Meyer T, Arndt R, Christophers E, Nindl I, Stockfleth E: Importance of human papillomaviruses for the development of skin cancer. Cancer Detect Prev 2001; 25: 533-547
89. Pfister H, Fuchs PG, Majewski S, Jablonska S, Pniewska I, Malejczyk M: High prevalence of epidermodysplasia verruciformis-associated human papillomavirus DNA in actinic keratoses of the immunocompetent population. Arch Dermatol Res 2003; 295: 273-279
90. Stockfleth E, Nindl I, Sterry W, Ulrich C, Schmook T, Meyer T: Human papillomaviruses in transplant-associated skin cancers. Dermatol Surg 2004; 30: 604-609
91. Andersson K, Waterboer T, Kirnbauer R, Slupetzky K, Iftner T, de Villiers EM, Forslund O, Pawlita M, Dillner J: Seroreactivity to cutaneous human papillomaviruses among patients with nonmelanoma skin cancer or benign skin lesions. Cancer Epidemiol Biomarkers Prev 2008; 17: 189-195
92. Forslund O, Lindelof B, Hradil E, Nordin P, Stenquist B, Kirnbauer R, Slupetzky K, Dillner J: High prevalence of cutaneous human papillomavirus DNA on the top of skin tumors but not in 'stripped' biopsies from the same tumors. J Invest Dermatol 2004; 123: 388-394
93. Meyer T, Arndt R, Nindl I, Ulrich C, Christophers E, Stockfleth E: Association of human papillomavirus infections with cutaneous tumors in immunosuppressed patients. Transpl Int 2003; 16: 146-153
94. Shamanin V, zur Hausen H, Lavergne D, Proby CM, Leigh IM, Neumann C, Hamm H, Goos M, Haustein UF, Jung EG, Plewig G, Wolff H, de Villiers EM: Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients. J Natl Cancer Inst 1996; 88: 802-811
95. Wieland U, Ritzkowsky A, Stoltidis M, Weissenborn S, Stark S, Ploner M, Majewski S, Jablonska S, Pfister HJ, Fuchs PG: Communication: papillomavirus DNA in basal cell carcinomas of immunocompetent patients: an accidental association? J Invest Dermatol 2000; 115: 124-128
96. Carter JJ, Koutsky LA, Hughes JP, Lee SK, Kuypers J, Kiviat N, Galloway DA: Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection. J Infect Dis 2000; 181: 1911-1919
97. Ho GY, Studentsov YY, Bierman R, Burk RD: Natural history of human papillomavirus type 16 viruslike particle antibodies in young women. Cancer Epidemiol Biomarkers Prev 2004; 13: 110-116
98. Kreimer AR, Alberg AJ, Viscidi R, Gillison ML: Gender differences in sexual biomarkers and behaviors associated with human papillomavirus-16,-18, and-33 seroprevalence. Sex Transm Dis 2004; 31: 247-256
99. Heiligenberg M, Michael KM, Kramer MA, Pawlita M, Prins M, Coutinho RA, Dukers-Muijrers NH, Waterboer T: Seroprevalence and determinants of eight high-risk human papillomavirus types in homosexual men, heterosexual men, and women: A population-based study in Amsterdam. Sex Transm Dis 2010; 37: 672-680
100. Plitt SS, Sherman SG, Viscidi RP, Strathdee SA, Fuller CM, Taha TE: Human papillomavirus seroprevalence among young male and female drug users. Sex Transm Dis 2007; 34: 676-680
101. Desai S, Chapman R, Jit M, Nichols T, Borrow R, Wilding M, Linford C, Lowndes CM, Nardone A, Pebody R, Soldan K: Prevalence of human papillomavirus antibodies in males and females in England. Sex Transm Dis 2011; 38: 622-629
102. Markowitz LE, Sternberg M, Dunne EF, McQuillan G, Unger ER: Seroprevalence of human papillomavirus types 6, 11, 16, and 18 in the United States: National Health and Nutrition Examination Survey 2003-2004. J Infect Dis 2009; 200: 1059-1067
103. Stone KM, Karem KL, Sternberg MR, McQuillan GM, Poon AD, Unger ER, Reeves WC: Seroprevalence of human papillomavirus type 16 infection in the United States. J Infect Dis 2002; 186: 1396-1402
104. Iannacone MR, Michael KM, Giuliano AR, Waterboer T, Pawlita M, Rollison DE: Risk factors for cutaneous human papillomavirus seroreactivity among patients undergoing skin cancer screening in Florida. J Infect Dis 2010; 201: 760-769
105. Michael KM, Waterboer T, Sehr P, Rother A, Reidel U, Boeing H, Bravo IG, Schlehofer J, Gartner BC, Pawlita M: Seroprevalence of 34 human papillomavirus types in the German general population. PLoS Pathog 2008; 4:e1000091
106. Kilkenny M, Merlin K, Young R, Marks R: The prevalence of common skin conditions in Australian school students. 1. Common, plane and plantar viral warts. Br J Dermatol 1998; 138: 840-845
107. Chen SL, Tsao YP, Lee JW, Sheu WC, Liu YT: Characterization and analysis of human papillomaviruses of skin warts. Arch Dermatol Res 1993; 285: 460-465
108. Casabonne D, Michael KM, Waterboer T, Pawlita M, Forslund O, Burk RD, Travis RC, Key TJ, Newton R: A prospective pilot study of antibodies against human papillomaviruses and cutaneous squamous cell carcinoma nested in the Oxford component of the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 2007; 121: 1862-1868
109. Iannacone MR, Gheit T, Waterboer T, Giuliano AR, Messina JL, Fenske NA, Cherpelis BS, Sondak VK, Roetzheim RG, Michael KM, Tommasino M, Pawlita M, Rollison DE: Case-control study of cutaneous human papillomaviruses in squamous cell carcinoma of the skin. Cancer Epidemiol Biomarkers Prev 2012; 21: 1303-1313
110. Antonsson A, Green AC, Mallitt KA, O'Rourke PK, Pandeya N, Pawlita M, Waterboer T, Neale RE: Prevalence and stability of antibodies to 37 human papillomavirus types-a population-based longitudinal study. Virology 2010; 407: 26-32
111. Forman D, de Martel C, Lacey CJ, Soerjomataram I, Lortet-Tieulent J, Bruni L, Vignat J, Ferlay J, Bray F, Plummer M, Franceschi S: Global burden of human papillomavirus and related diseases. Vaccine 2012; 30(suppl 5):F12-F23
112. Chaturvedi AK: Beyond cervical cancer: burden of other HPV-related cancers among men and women. J Adolesc Health 2010; 46:S20-S26
113. Surveillance, Epidemiology and End Results (SEER) Program: SEER Stat database: incidence-SEER 9 (1973-2005); total US (1969-2005); counties, National Cancer Institute, Surveillance Research Program, Cancer Statistics Branch (released April 2008, based on the November 2007 submission). 2008. www.seer.cancer.gov
114. Bonagura VR, Hatam LJ, Rosenthal DW, De Voti JA, Lam F, Steinberg BM, Abramson AL: Recurrent respiratory papillomatosis: A complex defect in immune responsiveness to human papillomavirus-6 and-11. APMIS 2010; 118: 455-470
115. Blomberg M, Friis S, Munk C, Bautz A, Kjaer SK: Genital warts and risk of cancer: A Danish study of nearly 50,000 patients with genital warts. J Infect Dis 2012; 205: 1544-1553
116. Jeynes C, Chung MC, Challenor R: 'Shame on you'-the psychosocial impact of genital warts. Int J STD AIDS 2009; 20: 557-560
117. Wiley DJ, Douglas J, Beutner K, Cox T, Fife K, Moscicki AB, Fukumoto L: External genital warts: diagnosis, treatment, and prevention. Clin Infect Dis 2002; 35:S210-S224
118. Lacey CJ: Therapy for genital human papillomavirus-related disease. J Clin Virol 2005; 32(suppl 1): S82-S90
119. Dinh TH, Sternberg M, Dunne EF, Markowitz LE: Genital warts among 18-to 59-year-olds in the United States, National Health and Nutrition Examination Survey, 1999-2004. Sex Transm Dis 2008; 35: 357-360
120. Anic GM, Lee JH, Stockwell H, Rollison DE, Wu Y, Papenfuss MR, Villa LL, Lazcano-Ponce E, Gage C, Silva RJ, Baggio ML, Quiterio M, Salmeron J, Abrahamsen M, Giuliano AR: Incidence and human papillomavirus (HPV) type distribution of genital warts in a multinational cohort of men: the HPV in Men Study. J Infect Dis 2011; 204: 1886-1892
121. Kraut AA, Schink T, Schulze-Rath R, Mikolajczyk RT, Garbe E: Incidence of anogenital warts in Germany: A population-based cohort study. BMC Infect Dis 2010; 10: 360
122. Van Den Eeden SK, Habel LA, Sherman KJ, Mc-Knight B, Stergachis A, Daling JR: Risk factors for incident and recurrent condylomata acuminata among men. A population-based study. Sex Transm Dis 1998; 25: 278-284
123. Wen LM, Estcourt CS, Simpson JM, Mindel A: Risk factors for the acquisition of genital warts: are condoms protective? Sex Transm Infect 1999; 75: 312-316
124. Garland SM, Steben M, Sings HL, James M, Lu S, Railkar R, Barr E, Haupt RM, Joura EA: Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine. J Infect Dis 2009; 199: 805-814
125. Cancer Facts and Figures 2013. Atlanta, American Cancer Society, 2013
126. Watson M, Saraiya M, Benard V, Coughlin SS, Flowers L, Cokkinides V, Schwenn M, Huang Y, Giuliano A: Burden of cervical cancer in the United States, 1998-2003. Cancer 2008; 113: 2855-2864
127. Schiffman M, Wentzensen N: From human papillomavirus to cervical cancer. Obstet Gynecol 2010; 116: 177-185
128. Safaeian M, Quint K, Schiffman M, Rodriguez AC, Wacholder S, Herrero R, Hildesheim A, Viscidi RP, Quint W, Burk RD: Chlamydia trachomatis and risk of prevalent and incident cervical premalignancy in a population-based cohort. J Natl Cancer Inst 2010; 102: 1794-1804
129. Smith JS, Backes DM, Hoots BE, Kurman RJ, Pimenta JM: Human papillomavirus type-distribution in vulvar and vaginal cancers and their associated precursors. Obstet Gynecol 2009; 113: 917-924
130. Dittmer C, Katalinic A, Mundhenke C, Thill M, Fischer D: Epidemiology of vulvar and vaginal cancer in Germany. Arch Gynecol Obstet 2011; 284: 169-174
131. Screening for Cervical Cancer. US Preventive Services Task Force. 2011. http://www.usprevent iveservicestaskforce.org/uspstf/uspscerv.htm (accessed June 10, 2011)
132. Bower M, Powles T, Newsom-Davis T, Thirlwell C, Stebbing J, Mandalia S, Nelson M, Gazzard B: HIVassociated anal cancer: has highly active antiretroviral therapy reduced the incidence or improved the outcome? J Acquir Immune Defic Syndr 2004; 37: 1563-1565
133. Chiao EY, Krown SE, Stier EA, Schrag D: A population-based analysis of temporal trends in the incidence of squamous anal canal cancer in relation to the HIV epidemic. J Acquir Immune Defic Syndr 2005; 40: 451-455
134. Cress RD, Holly EA: Incidence of anal cancer in California: increased incidence among men in San Francisco, 1973-1999. Prev Med 2003; 36: 555-560
135. Daling JR, Weiss NS, Klopfenstein LL, Cochran LE, Chow WH, Daifuku R: Correlates of homosexual behavior and the incidence of anal cancer. JAMA 1982; 247: 1988-1990
136. Diamond C, Taylor TH, Aboumrad T, Bringman D, Anton-Culver H: Increased incidence of squamous cell anal cancer among men with AIDS in the era of highly active antiretroviral therapy. Sex Transm Dis 2005; 32: 314-320
137. Frisch M, Biggar RJ, Goedert JJ: Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 2000; 92: 1500-1510
138. Nordenvall C, Nilsson PJ, Ye WM, Nyren O: Smoking, snus use and risk of right-and left-sided colon, rectal and anal cancer: A 37-year follow-up study. Int J Cancer 2011; 128: 157-165
139. Phillips DH, Hewer A, Scholefield JH, Skinner P: Smoking-related DNA adducts in anal epithelium. Mutat Res 2004; 560: 167-172
140. Bleeker MC, Heideman DA, Snijders PJ, Horenblas S, Dillner J, Meijer CJ: Penile cancer: epidemiology, pathogenesis and prevention. World J Urol 2009; 27: 141-150
141. Hernandez BY, Barnholtz-Sloan J, German RR, Giuliano A, Goodman MT, King JB, Negoita S, Villalon-Gomez JM: Burden of invasive squamous cell carcinoma of the penis in the United States, 1998-2003. Cancer 2008; 113: 2883-2891
142. Bosch FX, Cardis E: Cancer incidence correlations: genital, urinary and some tobacco-related cancers. Int J Cancer 1990; 46: 178-184
143. Daling JR, Madeleine MM, Johnson LG, Schwartz SM, Shera KA, Wurscher MA, Carter JJ, Porter PL, Galloway DA, McDougall JK, Krieger JN: Penile cancer: importance of circumcision, human papillomavirus and smoking in in situ and invasive disease. Int J Cancer 2005; 116: 606-616
144. Maden C, Sherman KJ, Beckmann AM, Hislop TG, Teh CZ, Ashley RL, Daling JR: History of circumcision, medical conditions, and sexual activity and risk of penile cancer. J Natl Cancer Inst 1993; 85: 19-24
145. Brinton LA, Li JY, Rong SD, Huang S, Sheng XB, Shi BG, Zhu ZJ, Schiffman MH, Dawsey S: Riskfactors for penile cancer: results from a case-control study in China. Int J Cancer 1991; 47: 504-509
146. IARC-WHO 2003. World Cancer Report. Geneva, International Agency for Research on Cancer-World Health Organization, 2003
147. Mork J, Lie AK, Glattre E, Hallmans G, Jellum E, Koskela P, Moller B, Pukkala E, Schiller JT, Youngman L, Lehtinen M, Dillner J: Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 2001; 344: 1125-1131
148. Gillison ML, D'Souza G, Westra W, Sugar E, Xiao W, Begum S, Viscidi R: Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 2008; 100: 407-420
149. D'Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, Westra WH, Gillison ML: Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007; 356: 1944-1956
150. Chaturvedi AK, Engels EA, Anderson WF, Gillison ML: Incidence trends for human papillomavirusrelated and-unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 2008; 26: 612-619
151. Donaldson MR, Coldiron BM: No end in sight: the skin cancer epidemic continues. Semin Cutan Med Surg 2011; 30: 3-5
152. Jemal A, Siegel R, Xu J, Ward E: Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277-300
153. Weinstock MA: Epidemiologic investigation of nonmelanoma skin cancer mortality: the Rhode Island Follow-Back Study. J Invest Dermatol 1994; 102: 6S-9S
154. Mudigonda T, Pearce DJ, Yentzer BA, Williford P, Feldman SR: The economic impact of non-melanoma skin cancer: A review. J Natl Compr Canc Netw 2010; 8: 888-896
155. Jablonska S, Dabrowski J, Jakubowicz K: Epidermodysplasia verruciformis as a model in studies on the role of papovaviruses in oncogenesis. Cancer Res 1972; 32: 583-589
156. Orth G: Genetics of epidermodysplasia verruciformis: insights into host defense against papillomaviruses. Semin Immunol 2006; 18: 362-374
157. Bouwes Bavinck JN, Plasmeijer EI, Feltkamp MC: Beta-papillomavirus infection and skin cancer. J Invest Dermatol 2008; 128: 1355-1358
158. De Jong-Tieben LM, Berkhout RJ, Smits HL, Bouwes Bavinck JN, Vermeer BJ, van der Woude FJ, ter Schegget J: High frequency of detection of epidermodysplasia verruciformis-associated human papillomavirus DNA in biopsies from malignant and premalignant skin lesions from renal transplant recipients. J Invest Dermatol 1995; 105: 367-371
159. Karagas MR, Nelson HH, Sehr P, Waterboer T, Stukel TA, Andrew A, Green AC, Bavinck JN, Perry A, Spencer S, Rees JR, Mott LA, Pawlita M: Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin. J Natl Cancer Inst 2006; 98: 389-395
160. Karagas MR, Waterboer T, Li Z, Nelson HH, Michael KM, Bavinck JN, Perry AE, Spencer SK, Daling J, Green AC, Pawlita M: Genus beta human papillomaviruses and incidence of basal cell and squamous cell carcinomas of skin: population based case-control study. BMJ 2010; 341:c2986
161. Feltkamp MC, Broer R, di Summa FM, Struijk L, van der Meijden E, Verlaan BP, Westendorp RG, ter Schegget J, Spaan WJ, Bouwes Bavinck JN: Seroreactivity to epidermodysplasia verruciformis-related human papillomavirus types is associated with nonmelanoma skin cancer. Cancer Res 2003; 63: 2695-2700
162. Hall L, Struijk L, Neale RE, Feltkamp MC: Re: human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin. J Natl Cancer Inst 2006; 98: 1425-1426
163. Iannacone MR, Wang W, Stockwell HG, O'Rourke K, Giuliano AR, Sondak VK, Messina JL, Roetzheim RG, Cherpelis BS, Fenske NA, Michael KM, Waterboer T, Pawlita M, Rollison DE: Sunlight exposure and cutaneous human papillomavirus seroreactivity in basal cell and squamous cell carcinomas of the skin. J Infect Dis 2012; 206: 399-406.